It is possible that the increased levels of serum EV miR-21-5p reflect the conditions of fibrotic lung diseases, including IPF, in which TGF-β signalling is one of the most relevant signalling pathways. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.